Li Auto (NASDAQ: LI, HK: 2015) shares tumbled on Monday after the Chinese EV maker reported weaker-than-expected earnings and issued a soft revenue forecast. The stock fell as much as 7% to HK$105.0 in Hong Kong, underperforming the Hang Seng Index’s 1% gain. This followed a 4.3% decline in its U.S. shares on Friday.
The company, competing with Tesla (NASDAQ: TSLA) in China, projected Q1 revenue between 23.4 billion yuan and 24.7 billion yuan ($3.2 billion–$3.4 billion), missing market estimates of 33.5 billion yuan. This outlook overshadowed its record-high Q4 revenue of 44.3 billion yuan. Earnings per share dropped to 10.04 yuan from the previous year due to a fierce price war in China’s EV market.
Li Auto’s disappointing guidance triggered analyst downgrades. Macquarie cut its rating to Neutral from Outperform, citing concerns over profit growth amid rising competition. Nomura also downgraded the stock to Neutral, noting increased pressure from upcoming rival models.
Despite strong sales growth, Li Auto’s margins have been squeezed by aggressive pricing strategies among Chinese automakers. The company plans to launch two new all-electric SUVs, the Li i8 and Li i6, in 2025. However, industry conditions may improve as Beijing considers new subsidies to stimulate EV demand.
Meanwhile, shares of competitors BYD (HK: 1211), NIO (HK: 9866), and Xpeng (HK: 9868) gained up to 3.7% on Monday, benefiting from Li Auto’s struggles.
Investors remain cautious about the Chinese EV sector’s profitability, but potential government support could provide a boost in the coming months.


iRobot Files for Chapter 11 Bankruptcy Amid Rising Competition and Tariff Pressures
Trello Outage Disrupts Users as Access Issues Hit Atlassian’s Work Management Platform
Coca-Cola’s Proposed Sale of Costa Coffee Faces Uncertainty Amid Price Dispute
SpaceX Insider Share Sale Values Company Near $800 Billion Amid IPO Speculation
Nvidia Weighs Expanding H200 AI Chip Production as China Demand Surges
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit
Korea Zinc Plans $6.78 Billion U.S. Smelter Investment With Government Partnership
Korea Zinc to Build $7.4 Billion Critical Minerals Refinery in Tennessee With U.S. Government Backing
FDA Says No Black Box Warning Planned for COVID-19 Vaccines Despite Safety Debate
Biren Technology Targets Hong Kong IPO to Raise $300 Million Amid China’s AI Chip Push
Azul Airlines Wins Court Approval for $2 Billion Debt Restructuring and New Capital Raise
Coca-Cola’s Costa Coffee Sale Faces Uncertainty as Talks With TDR Capital Hit Snag
Ford Takes $19.5 Billion Charge as EV Strategy Shifts Toward Hybrids
EU Signals Major Shift on 2035 Combustion Engine Ban Amid Auto Industry Pressure
SpaceX Begins IPO Preparations as Wall Street Banks Line Up for Advisory Roles
Woolworths Faces Fresh Class Action Over Alleged Underpayments, Shares Slide
Strategy Retains Nasdaq 100 Spot Amid Growing Scrutiny of Bitcoin Treasury Model 



